Answers are grounded in this paper and cite their sources.
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of basal cell carcinoma (BCC). The document aims to: offer an appraisal of all relevant literature up to 24(th) January 2020 focusing on any key developments address important, practical clinical questions relating to the primary guideline objective provide guideline recommendations and if appropriate research recommendations.
No takes yet. Share an insight, caveat, or question.
Nasr et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: